2016

In this week’s Q&A, we interview Afzal A. Siddiqui, an immunology and molecular biology professor at the Texas Tech University School of Medicine.

A new gene-editing technique may lead to new treatment for people with the most severe form of muscular dystrophy.

New research showing that a liver hormone regulates certain food and alcohol preferences raises the possibility of new ways to eventually treat diet imbalances and alcoholism.

In this week’s Bookshelf, our content partner Kirkus Reviews highlights A Cancer In The Family.

A new study finds that the stereotypic “sudden’’ heart attack often is preceded by subtle warning signs, meaning lives could be saved if more people recognized the early signs and got help immediately.

The World Health Organization declared Guinea free of the deadly Ebola virus in late December, a long-awaited public health triumph over an illness that killed more than 2,500 people in the past two years.

The healthcare industry will see greater movement on recent trends in 2016, including more institutional mergers, cyber-threats to medical technology and a continued push to shift care to lower cost, community settings.

A federal spending bill signed into law by President Obama in December includes a $2 billion increase for the National Institutes of Health.

Dr. Alfred G. Gilman, a UT Southwestern pharmacologist whose work earned him a shared Nobel Prize in Physiology or Medicine in 1994, died in Dallas at age 74.